# FDA Approves Arsenic Trioxide Generic from Zydus Pharmaceuticals The FDA has approved Zydus Pharmaceuticals USA Inc.'s generic arsenic trioxide int...
Financial News Archive
SEC EDGAR · Federal Reserve · FDA · BLS · Updated every 60s
ALVOGEN announced on November 8, 2018, the approval of its Abbreviated New Drug Application (ANDA208540), signaling the company's strategic expansion ...
Camber Pharmaceuticals, Inc. received FDA approval for Abbreviated New Drug Application #211487 covering hydrocodone bitartrate and acetaminophen oral...
Unichem Pharmaceuticals (USA), Inc. announced today the receipt of approval for ANDA207429 to manufacture the oral tablets of Sotalol Hydrochloride, a...
Here are two sentences for a financial newswire: AUROLIFE PHARMA LLC capitalizes on market share by securing FDA approval for N/A, advancing its entr...
FDA approved the ANDA for Metformin Hydrochloride manufactured by Ascend Laboratories, LLC, granting the firm market authorization for the generic ver...
On October 16, 2018, U.S. Pharmaceuticals received FDA approval for Talzenna (talazoparib tosylate), a targeted oral therapy for advanced breast cance...
Camber Pharmaceuticals, Inc. received FDA approval for oral atovaquone, reinforcing market expectations for increased generic penetration and pressure...
On October 2, 2018, Paratek Pharmaceuticals received FDA approval for NUZYRA (omadacycline), an oral antibiotic poised to address treatment gaps cause...
Paratek Pharmaceuticals received FDA approval on October 2, 2018, to market the intravenous antibiotic NUZYRA (omadacycline) under New Drug Applicatio...
Brookline, Massachusetts-based Insmed Incorporated announced Wednesday that JAMA reports suggest the amikacin inhaled formulation ARIKAYCE could impro...
On September 27, 2018, Eli Lilly and Company received FDA approval for the brand-name treatment EMGALITY (galcanezumab-gnlm), a structural analog of g...
FDA granted approval Tuesday to Epic Pharma for a generic ANDA filing, adding another formulation of metformin hydrochloride to the schedule of availa...
Fresenius Kabi USA, LLC announced the approval of generic palonosetron hydrochloride by the FDA on September 19, 2018, offering a less expensive alter...
Fresenius Kabi USA has secured FDA approval to manufacture the anti-emetic drug palonsetron hydrochloride under ANDA 206802. This approval introduces ...
Teva Pharmaceuticals USA, Inc. announced FDA approval for Fremanezumab subcutaneously, a move poised to intensify competitive pricing in the migraine ...
Breckenridge Pharmaceuticals has secured FDA approval for ANDA 208283 regarding oral eplerenone, introducing an additional generic option that is expe...
Merck Sharp & Dohme (MSD) announced the FDA approval of Brand DELSTRIGO, a single-tablet regimen combining doravirine, lamivudine, and tenofovir disop...
Upsher-Smith Laboratories, LLC has received approval for its Abbreviated New Drug Application (ANDA) 205231 to manufacture generic DILTIAZEM HYDROCHLO...
Laurus Labs Limited received FDA approval on August 27, 2018, for its ANDA209882 to manufacture the oral tablet formulation of Metformin Hydrochloride...